We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVLG icon
2651
Covenant Logistics
CVLG
$872M
$175 ﹤0.01%
8
– –
EFT
2652
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$175 ﹤0.01%
15
– –
HSII
2653
DELISTED
Heidrick & Struggles
HSII
$159 ﹤0.01%
6
– –
IWY icon
2654
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$159 ﹤0.01%
1
– –
AMC icon
2655
AMC Entertainment Holdings
AMC
$2.31B
$158 ﹤0.01%
4
-37
-90% -$1.83K
NWS icon
2656
News Corp Class B
NWS
$17.5B
$158 ﹤0.01%
8
– –
CIO
2657
DELISTED
City Office REIT
CIO
$156 ﹤0.01%
28
-54
-66% -$294
SER icon
2658
Serina Therapeutics
SER
$36M
$154 ﹤0.01%
5
– –
BTAI icon
2659
BioXcel Therapeutics
BTAI
$27.8M
$147 ﹤0.01%
1
– –
ERIC icon
2660
Ericsson
ERIC
$33.3B
$142 ﹤0.01%
26
-361
-93% -$1.94K
BINI
2661
DELISTED
Bollinger Innovations
BINI
– –
0
– –
KYNB
2662
Kyntra Bio
KYNB
$29.4M
$105 ﹤0.01%
2
-21
-91% -$8.69K
ONCT
2663
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$104 ﹤0.01%
15
– –
ECPG icon
2664
Encore Capital Group
ECPG
$2.13B
$97 ﹤0.01%
2
– –
LAUR icon
2665
Laureate Education
LAUR
$5.28B
$97 ﹤0.01%
8
– –
FIW icon
2666
First Trust Water ETF
FIW
$1.94B
$89 ﹤0.01%
1
– –
ILF icon
2667
iShares Latin America 40 ETF
ILF
$3.76B
$82 ﹤0.01%
3
– –
QQQJ icon
2668
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
$78 ﹤0.01%
3
-31
-91% -$779
GCO icon
2669
Genesco
GCO
$422M
$75 ﹤0.01%
3
-7
-70% -$203
BPOP icon
2670
Popular Inc
BPOP
$11.1B
$61 ﹤0.01%
1
– –
INDA icon
2671
iShares MSCI India ETF
INDA
$6.63B
$61 ﹤0.01%
1
– –
SLG icon
2672
SL Green Realty
SLG
$3.99B
$60 ﹤0.01%
2
-8
-80% -$193
PHO icon
2673
Invesco Water Resources ETF
PHO
$2.09B
$56 ﹤0.01%
1
– –
INKT icon
2674
MiNK Therapeutics
INKT
$54.6M
$55 ﹤0.01%
+3
New +$60
AVUV icon
2675
Avantis US Small Cap Value ETF
AVUV
$30.9B
$54 ﹤0.01%
1
– –
105 106
107
108 109

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.